Skip to main content
Top
Literature
1.
4.
go back to reference Riley RS, McPherson RA (2016) Basic Examination of Urine. In: McPherson RA, Pincus MR (eds) Henry’s Clinical Diagnosis and Management by Laboratory Methods. Elsevier, St. Louis, Missouri, pp 442–480 Riley RS, McPherson RA (2016) Basic Examination of Urine. In: McPherson RA, Pincus MR (eds) Henry’s Clinical Diagnosis and Management by Laboratory Methods. Elsevier, St. Louis, Missouri, pp 442–480
5.
go back to reference Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 82(3):421–426CrossRefPubMed Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 82(3):421–426CrossRefPubMed
Metadata
Title
Solubility of crystals in acetone: a diagnostic tool for crystalluria
Authors
Yoshito Iida
Masayuki Tanemoto
Takahiro Kasai
Seiji Inoshita
Publication date
30-04-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 12/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03614-0

Other articles of this Issue 12/2023

International Urology and Nephrology 12/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine